167 related articles for article (PubMed ID: 29511289)
21. IFIT5 positively regulates NF-κB signaling through synergizing the recruitment of IκB kinase (IKK) to TGF-β-activated kinase 1 (TAK1).
Zheng C; Zheng Z; Zhang Z; Meng J; Liu Y; Ke X; Hu Q; Wang H
Cell Signal; 2015 Dec; 27(12):2343-54. PubMed ID: 26334375
[TBL] [Abstract][Full Text] [Related]
22. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
[TBL] [Abstract][Full Text] [Related]
23. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
[TBL] [Abstract][Full Text] [Related]
24. The TAK1-NF-κB axis as therapeutic target for AML.
Bosman MC; Schepers H; Jaques J; Brouwers-Vos AZ; Quax WJ; Schuringa JJ; Vellenga E
Blood; 2014 Nov; 124(20):3130-40. PubMed ID: 25287709
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
[TBL] [Abstract][Full Text] [Related]
26. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling.
Li X; Jin Q; Wu YL; Sun P; Jiang S; Zhang Y; Zhang DQ; Zhang YJ; Lian LH; Nan JX
Int Immunopharmacol; 2016 Jul; 36():263-270. PubMed ID: 27179306
[TBL] [Abstract][Full Text] [Related]
27. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
28. Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention.
Meng F; Li Y; Tian X; Fu L; Yin Y; Sui C; Ma P; Jiang Y
Biochem Biophys Res Commun; 2014 Oct; 453(1):106-11. PubMed ID: 25261726
[TBL] [Abstract][Full Text] [Related]
29. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
30. Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.
Cai PC; Shi L; Liu VW; Tang HW; Liu IJ; Leung TH; Chan KK; Yam JW; Yao KM; Ngan HY; Chan DW
Oncotarget; 2014 Sep; 5(17):7549-62. PubMed ID: 25277189
[TBL] [Abstract][Full Text] [Related]
31. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
[TBL] [Abstract][Full Text] [Related]
32. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.
Nicolay JP; Müller-Decker K; Schroeder A; Brechmann M; Möbs M; Géraud C; Assaf C; Goerdt S; Krammer PH; Gülow K
Blood; 2016 Aug; 128(6):805-15. PubMed ID: 27268084
[TBL] [Abstract][Full Text] [Related]
33. Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells.
Ota K; Kawaguchi M; Fujita J; Kokubu F; Huang SK; Morishima Y; Matsukura S; Kurokawa M; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Exp Lung Res; 2015; 41(6):335-43. PubMed ID: 26151454
[TBL] [Abstract][Full Text] [Related]
34. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
Yao F; Zhou W; Zhong C; Fang W
Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
[TBL] [Abstract][Full Text] [Related]
35. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
36. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling.
Yamazaki K; Gohda J; Kanayama A; Miyamoto Y; Sakurai H; Yamamoto M; Akira S; Hayashi H; Su B; Inoue J
Sci Signal; 2009 Oct; 2(93):ra66. PubMed ID: 19843958
[TBL] [Abstract][Full Text] [Related]
37. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
38. Induction of nuclear factor-kappaB activation through TAK1 and NIK by diesel exhaust particles in L2 cell lines.
Yun YP; Joo JD; Lee JY; Nam HY; Kim YH; Lee KH; Lim CS; Kim HJ; Lim YG; Lim Y
Toxicol Lett; 2005 Feb; 155(2):337-42. PubMed ID: 15603929
[TBL] [Abstract][Full Text] [Related]
39. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
Yumeen S; Girardi M
Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
[TBL] [Abstract][Full Text] [Related]
40. Essential role of TAK1 in regulating mantle cell lymphoma survival.
Buglio D; Palakurthi S; Byth K; Vega F; Toader D; Saeh J; Neelapu SS; Younes A
Blood; 2012 Jul; 120(2):347-55. PubMed ID: 22649101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
